ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shigefumi Suehiro
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizuguchi, S.
Right arrow Articles by Suehiro, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizuguchi, S.
Right arrow Articles by Suehiro, S.
Related Collections
Right arrow Lung - cancer
Right arrowRelated Article

Ann Thorac Surg 2007;83:216-221
© 2007 The Society of Thoracic Surgeons


Original Articles: General Thoracic

Clinical Value of Serum Cytokeratin 19 Fragment and Sialyl-Lewis X in Non-Small Cell Lung Cancer

Shinjiro Mizuguchi, MD, PhDa,b,*, Noritoshi Nishiyama, MD, PhDa, Takashi Iwata, MD, PhDa, Tatsuya Nishida, MD, PhDa, Nobuhiro Izumi, MD, PhDa, Takuma Tsukioka, MDa, Kiyotoshi Inoue, MD, PhDa,b, Masao Kameyama, MD, PhDb, Shigefumi Suehiro, MD, PhDc

a Department of Thoracic Surgery, Osaka City University Hospital, Osaka, Japan
b Department of Thoracic Surgery, Bell Land General Hospital, Osaka, Japan
c Department of Cardiovascular Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan

Accepted for publication August 23, 2006.

* Address correspondence to Dr Mizuguchi, Department of Thoracic Surgery, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan (Email: m1293795{at}msic.med.osaka-cu.ac.jp).

BACKGROUND: This study aimed to establish the clinical significance of preoperative serum cytokeratin 19 fragment (CYFRA21-1) and sialyl-Lewis x (SLex) as prognostic markers.

METHODS: The study involved 272 patients (181 male, 91 female; median age 69 years; range, 32 to 92) with non-small cell lung cancer (NSCLC) who underwent pulmonary resection with mediastinal lymph node dissection. Tumor markers carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC), CYFRA21-1, and SLex were examined.

RESULTS: A log-rank test revealed that age, gender, performance status, CEA, SCC, CYFRA21-1, and SLex were associated with the survival rate. By multivariate analysis, age, gender, performance status, CYFRA21-1 (risk ratio, 2.42) and SLex (risk ratio, 6.18) were independent prognostic factors. For patients positive for both markers, the relative risk was 6.10 compared with patients negative for both markers. The patients were divided into three groups: negative for both CYFRA21-1 and SLex (n = 97); positive for either marker (n = 136); and positive for both markers (n = 39). The 1-, 3-, and 5-year survival rates were the following: 98%, 82%, and 75% in the first group; 90%, 63%, and 49% in the second group; and 62%, 31%, and 25% in the third group (p < 0.001). Sixty-four percent of patients positive for both markers were histologic stage III/IV, and 68% of patients negative for both markers were stage I.

CONCLUSIONS: Serum CYFRA21-1 and SLex were prognostic markers for NSCLC. Their combination should contribute to the classification of NSCLC patients. Preoperative staging should be carefully performed in patients positive for both tumor markers.


Related Article

Invited commentary
Thomas D’Amico
Ann. Thorac. Surg. 2007 83: 221-222. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
T. Uenishi, O. Yamazaki, H. Tanaka, S. Takemura, T. Yamamoto, S. Tanaka, S. Nishiguchi, and S. Kubo
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
Ann. Surg. Oncol., February 1, 2008; 15(2): 583 - 589.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
H.-J. Haussmann
Smoking and Lung Cancer: Future Research Directions
International Journal of Toxicology, July 1, 2007; 26(4): 353 - 364.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. D'Amico
Invited commentary
Ann. Thorac. Surg., January 1, 2007; 83(1): 221 - 222.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.